Dapagliflozin DPPIV Inhibitor add-on Study
Public ClinicalTrials.gov record NCT00984867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, International Phase III Study With 24 Week Extension to Evaluate the Safety and Efficacy of Dapagliflozin 10 mg/Day in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on a DPP-4 Inhibitor Sitagliptin+/-Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.
Study identification
- NCT ID
- NCT00984867
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 833 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Feb 28, 2011
- Completion
- Aug 31, 2011
- Last update posted
- Jun 12, 2014
2009 – 2011
United States locations
- U.S. sites
- 45
- U.S. states
- 21
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | — | — |
| Research Site | Ozark | Alabama | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Chula Vista | California | — | — |
| Research Site | Greenbrae | California | — | — |
| Research Site | Laguna Hills | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Riverside | California | — | — |
| Research Site | West Hills | California | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | DeLand | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Longwood | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Port Orange | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Stone Mountain | Georgia | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Lake Charles | Louisiana | — | — |
| Research Site | Edina | Minnesota | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Pahrump | Nevada | — | — |
| Research Site | Staten Island | New York | — | — |
| Research Site | Wilmington | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Medord | Oregon | — | — |
| Research Site | Lancaster | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Mt. Pleasant | South Carolina | — | — |
| Research Site | Myrtle Beach | South Carolina | — | — |
| Research Site | Simpsonville | South Carolina | — | — |
| Research Site | Bristol | Tennessee | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | North Richland Hills | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Burke | Virginia | — | — |
| Research Site | Manassas | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Lakewood | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00984867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2014 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00984867 live on ClinicalTrials.gov.